Forensic laboratories need fast answers, but they also need defensible results. Case backlogs, emerging drugs, complex mixtures, and time-sensitive investigations place pressure on screening workflows. Scientists must identify likely compounds, prioritize samples, and decide when a case requires deeper analysis.
Direct analysis in real time mass spectrometry, or DART-MS, offers a fast front-end tool for that work. According to NIST forensic guidance, DART-MS can produce real-time results with little to no sample preparation, which makes it attractive for rapid seized-drug screening. The technique can analyze powders, tablets, residues, extracts, and other sample types, giving analysts rapid chemical information before confirmatory testing begins.
DART-MS works best as a screening and triage technique. It can help forensic scientists move faster, but it does not replace validated LC-MS/MS, GC-MS, or other confirmatory methods when results support legal decisions.
Why Forensic Labs Use DART-MS
Forensic screening often begins with one question: what is this sample likely to contain?
DART-MS can help answer that question in seconds. Analysts can screen a tablet, powder, or residue and generate mass spectral information with minimal handling. When paired with high-resolution MS, in-source fragmentation, and forensic libraries, DART-MS can support rapid tentative identification. The DART-MS forensics database from NIST includes evaluated in-source CID spectra for forensic compounds, including seized drugs and cutting agents.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
This speed can help laboratories sort routine samples from unusual or high-risk cases. It can also support early awareness of emerging substances, especially when drug markets change faster than standard workflows can adapt.
Seized Drugs, Toxicology, and Trace Evidence
Seized drug analysis remains one of the clearest forensic uses for DART-MS. The technique can screen tablets, powders, residues, and mixtures for controlled substances, cutting agents, excipients, and emerging compounds. A seized-drug case study demonstrated DART-MS with the NIST/NIJ data interpretation tool on 92 adjudicated seized-drug case samples. That kind of workflow can help analysts decide which samples need full confirmation and which require additional investigation.
Toxicology offers another potential use, though biological matrices create greater analytical demands. Blood, urine, oral fluid, and tissue extracts contain salts, metabolites, proteins, and endogenous compounds that can affect signal quality. DART-MS may help screen for drugs of abuse or toxicology-relevant compounds, but laboratories still need validated methods across each matrix and concentration range.
DART-MS can also support trace evidence investigations. A forensic DART-MS review covers drugs of abuse, gunshot residue, printer inks, and other forensic samples. In these workflows, the technique can provide rapid chemical clues that guide follow-up testing.
What DART-MS Cannot Do Alone
Speed creates value only when the laboratory understands the method’s limits. Forensic samples often contain mixtures, matrix components, degradation products, and compounds that share mass spectral features. Without chromatographic separation, analysts need strong interpretation rules.
Key constraints include:
- Mixture complexity: Multiple compounds can produce overlapping signals.
- Matrix effects: Sample composition can suppress or enhance response.
- Library gaps: New or uncommon compounds may not match reference data.
- Quantitation limits: Screening data may not support formal concentration reporting.
- Legal defensibility: Casework results require validation, documentation, and confirmation.
These limits define the best role for DART-MS. It can guide the next analytical step, but it should not carry conclusions beyond what the method supports.
Building a Defensible Workflow
A forensic DART-MS method needs a clear purpose. Laboratories should define whether the method supports preliminary screening, tentative identification, mixture triage, or investigative support.
That purpose should shape validation. Analysts need to test target compound coverage, mixture performance, sensitivity, carryover, contamination control, and false positive and false negative behavior. They also need clear confirmation triggers. A rapid screen should make the next step clearer, not blur the line between screening and reporting.
Faster Screening Without Losing Rigor
DART-MS gives forensic laboratories a faster way to screen samples and prioritize confirmatory resources. Its value lies in early decision-making: identifying likely compounds, flagging complex samples, and guiding deeper analysis.
Used with clear limits, strong data tools, and defined confirmation pathways, DART-MS can strengthen forensic workflows. It helps scientists reach the right next test faster while preserving the rigor that forensic casework demands.
